XTX Topco’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

XTX Topco’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-28,145	Closed	-$18.6K	–	2745
2024 Q2	$18.6K	Buy	+28,145	New	+$17.5K	﹤0.01%	1622

XTX Topco's VBIV Position: Q3 2024 in Review

XTX Topco sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2024, closing a stake of 28,145 shares — an estimated $18.6K sold.

XTX Topco first reported a position in VBIV in Q2 2024 and held it in 1 quarter. The position peaked at $18.6K in Q2 2024. 1 fund tracked by Wall St. Rank holds VBIV as of Q3 2024.

XTX Topco reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q3 2024 after selling out during the quarter.
XTX Topco sold 28,145 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q3 2024, an estimated $18.6K.
XTX Topco first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2024 and held it in 1 quarter.
XTX Topco's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $18.6K in Q2 2024.
1 fund tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2024.

Based on XTX Topco's 13F filing for Q3 2024, filed 14 Nov 2024.